Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12
Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
The programme will be implemented across 13 states and benefit 256 min
The final data from the trial showed sotrovimab reduces hospitalisation and risk of death by 79% in adults with mild-to-moderate Covid-19 who are at high risk of progression to severe disease
Carestream equipment is highly recommended for its imaging quality
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Key takeaways of recent quarter & conference call highlights
The company is continuing with the evaluation of canakinumab in lung cancer, and is applying findings to the overall lung cancer development plan
The kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Klifovet’s client base comprises the world’s top animal health and nutrition companies as well as many promising startups
Subscribe To Our Newsletter & Stay Updated